---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-016519"
form_type: "8-K"
ticker: "LGVN"
cik: "0001721484"
company_name: "Longeveron Inc."
filed_at: "2026-02-13T23:59:59+00:00"
generated_at: "2026-05-16T02:48:10.568056+00:00"
event_type: "leadership"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Longeveron appoints Stephen Willard as CEO; Powell resigns; 50% salary deferral enacted

## Summary
- Stephen H. Willard appointed permanent CEO effective Feb 11, 2026; succeeds interim CEO Than Powell who remains in BD role.
- Willard receives base salary $500K/yr, deferred to $250K during temporary 50% deferral period for CEO and Executive Chairman.
- Initial equity grant: 200K shares, 200K RSUs, 200K stock option; all vest quarterly over four years.
- Company implements cost reductions: 50% salary deferral for CEO/Exec Chairman, furloughs, reduced board fees; 50K RSUs to each exec.
- Pivotal Phase 2b HLHS trial top-line results expected Q3 2026; FDA guidance that success could support BLA filing.

## SEC filing metadata
- accession: 0001213900-26-016519
- form_type: 8-K
- ticker: LGVN
- cik: 0001721484
- company_name: Longeveron Inc.
- filed_at: 2026-02-13T23:59:59+00:00
- event_type: leadership
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1721484/000121390026016519/0001213900-26-016519-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1721484/000121390026016519/ea0277101-8k_longeveron.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-016519
- JSON: https://secwatch.observer/filing/0001213900-26-016519.json
- Plain text: https://secwatch.observer/filing/0001213900-26-016519.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.